COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study. (2022)

First Author: Alexander JL
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(22)00274-6

PubMed Identifier: 36088954

Publication URI: http://europepmc.org/abstract/MED/36088954

Type: Journal Article/Review

Volume: 7

Parent Publication: The lancet. Gastroenterology & hepatology

Issue: 11